Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.730
+0.410 (31.06%)
At close: May 13, 2025, 4:00 PM
1.750
+0.020 (1.16%)
Pre-market: May 14, 2025, 8:56 AM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $268.36 million as of May 14, 2025. Its market cap has decreased by -42.22% in one year.
Market Cap
268.36M
Enterprise Value
287.78M
1-Year Change
-42.22%
Ranking
Category
Stock Price
$1.73
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $268.36M, an increase of 115.88%. That is a compound annual growth rate of 18.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 204.76M | -68.49% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |